Network Pharmacology and Pharmacological Mechanism of CV-3 in Atrial Fibrillation

Figure 4

Molecular docking analysis between the two key components of CV-3 and PTGS2. (a) Docking studies of human PTGS2 with N-decanoic acid and (b) spathulenol. Protein structures are shown as cyan cartoon and molecules as green sticks. Residues involved in hydrogen bonding interaction (yellow dash lines) have been shown in stick (purple).

(a)

(b)